203 related articles for article (PubMed ID: 10906441)
1. In vitro cytotoxicity tests on cultured human skin fibroblasts to predict skin irritation potential of surfactants.
Lee JK; Kim DB; Kim JI; Kim PY
Toxicol In Vitro; 2000 Aug; 14(4):345-9. PubMed ID: 10906441
[TBL] [Abstract][Full Text] [Related]
2. MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants.
Korting HC; Schindler S; Hartinger A; Kerscher M; Angerpointner T; Maibach HI
Life Sci; 1994; 55(7):533-40. PubMed ID: 8041231
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays.
Martinez V; Corsini E; Mitjans M; Pinazo A; Vinardell MP
Toxicol Lett; 2006 Jul; 164(3):259-67. PubMed ID: 16472949
[TBL] [Abstract][Full Text] [Related]
4. An approach for development of alternative test methods based on mechanisms of skin irritation.
Osborne R; Perkins MA
Food Chem Toxicol; 1994 Feb; 32(2):133-42. PubMed ID: 8132172
[TBL] [Abstract][Full Text] [Related]
5. Assessment of primary eye and skin irritants by in vitro cytotoxicity and phototoxicity models: an in vitro approach of new arginine-based surfactant-induced irritation.
Benavides T; Mitjans M; Martínez V; Clapés P; Infante MR; Clothier RH; Vinardell MP
Toxicology; 2004 May; 197(3):229-37. PubMed ID: 15033545
[TBL] [Abstract][Full Text] [Related]
6. The benefits of the 3T3 NRU test in the safety assessment of cosmetics: long-term experience from pre-marketing testing in the Czech Republic.
Jírová D; Kejlová K; Brabec M; Bendová H; Kolárová H
Toxicol In Vitro; 2003; 17(5-6):791-6. PubMed ID: 14599479
[TBL] [Abstract][Full Text] [Related]
7. Measurement of cytotoxicity and irritancy potential of sugar-based surfactants on skin-related 3D models.
Lu B; Miao Y; Vigneron P; Chagnault V; Grand E; Wadouachi A; Postel D; Pezron I; Egles C; Vayssade M
Toxicol In Vitro; 2017 Apr; 40():305-312. PubMed ID: 28163247
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the potential skin irritation of lysine-derivative anionic surfactants using mouse fibroblasts and human keratinocytes as an alternative to animal testing.
Sanchez L; Mitjans M; Infante MR; Vinardell MP
Pharm Res; 2004 Sep; 21(9):1637-41. PubMed ID: 15497690
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HaCaT cells and 3T3 mouse fibroblasts: correlation with in vivo data from a soap chamber assay.
Korting HC; Herzinger T; Hartinger A; Kerscher M; Angerpointner T; Maibach HI
J Dermatol Sci; 1994 Apr; 7(2):119-29. PubMed ID: 8060913
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on the ocular and dermal irritation potential of surfactants.
Mehling A; Kleber M; Hensen H
Food Chem Toxicol; 2007 May; 45(5):747-58. PubMed ID: 17169473
[TBL] [Abstract][Full Text] [Related]
11. Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test.
Kim CW; Kim CD; Choi KC
J Pharmacol Toxicol Methods; 2017; 88(Pt 2):130-139. PubMed ID: 28827132
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of primary skin irritants in vitro in a cytotoxicity model: comparison with in vivo human irritation tests.
Wilhelm KP; Böttjer B; Siegers CP
Br J Dermatol; 2001 Nov; 145(5):709-15. PubMed ID: 11736893
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid release: an in vitro alternative for dermal irritancy testing.
DeLeo VA; Carver MP; Hong J; Fung K; Kong B; DeSalva S
Food Chem Toxicol; 1996 Feb; 34(2):167-76. PubMed ID: 8606033
[TBL] [Abstract][Full Text] [Related]
14. In-house assessment of a modified in vitro cytotoxicity assay for higher throughput estimation of acute toxicity.
King AV; Jones PA
Toxicol In Vitro; 2003; 17(5-6):717-22. PubMed ID: 14599468
[TBL] [Abstract][Full Text] [Related]
15. Arachidonic acid release and prostaglandin E2 synthesis as irritant index of surfactants in 3T6 fibroblast cultures.
Moreno JJ
Toxicology; 2000 Mar; 143(3):275-82. PubMed ID: 10755713
[TBL] [Abstract][Full Text] [Related]
16. Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol.
Katoh M; Hamajima F; Ogasawara T; Hata K
J Toxicol Sci; 2009 Jun; 34(3):327-34. PubMed ID: 19483386
[TBL] [Abstract][Full Text] [Related]
17. Skin2--an in vitro human skin model: the correlation between in vivo and in vitro testing of surfactants.
Demetrulias J; Donnelly T; Morhenn V; Jessee B; Hainsworth S; Casterton P; Bernhofer L; Martin K; Decker D
Exp Dermatol; 1998 Feb; 7(1):18-26. PubMed ID: 9517918
[TBL] [Abstract][Full Text] [Related]
18. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols.
Tornier C; Rosdy M; Maibach HI
Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985
[TBL] [Abstract][Full Text] [Related]
19. An in vitro model for detecting skin irritants: methyl green-pyronine staining of human skin explant cultures.
Jacobs JJ; Lehé C; Cammans KD; Das PK; Elliott GR
Toxicol In Vitro; 2002 Oct; 16(5):581-8. PubMed ID: 12206825
[TBL] [Abstract][Full Text] [Related]
20. Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan).
Sugiyama M; Akita M; Alépée N; Fujishiro M; Hagino S; Handa Y; Ikeda H; Imai N; Jitsukawa S; Katoh M; Kurihara K; Kyotani D; Nomura S; Okamoto Y; Okumura H; Omori T; Sugibayashi K; Todo H; Toyoda A; Ohno Y
J Toxicol Sci; 2018; 43(12):751-768. PubMed ID: 30518713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
